# Alirocumab in Patients With Acute Myocardial Infarction

> **NCT02938949** · PHASE4 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 20 (actual)

## Conditions studied

- Myocardial Infarction
- Hypercholesterolemia

## Interventions

- **DRUG:** alirocumab
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02938949
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2018-08
- **Final completion:** 2018-08-16
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-09-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02938949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02938949, "Alirocumab in Patients With Acute Myocardial Infarction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02938949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*